| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/30/1999 | WO1999041387A3 Prostate-associated serine protease |
| 09/30/1999 | WO1999039741A3 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 09/30/1999 | WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 09/30/1999 | WO1999035277A3 Recombinant, active caspases and uses thereof |
| 09/30/1999 | WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor |
| 09/30/1999 | WO1999031261A9 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS |
| 09/30/1999 | WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
| 09/30/1999 | CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase |
| 09/30/1999 | CA2325631A1 Therapy of estrogen-associated disorders |
| 09/30/1999 | CA2325417A1 Halimide, a cytotoxic marine natural product, and derivatives thereof |
| 09/30/1999 | CA2324895A1 Novel cephalotaxane derivatives and process for their preparation |
| 09/30/1999 | CA2324616A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 09/30/1999 | CA2324610A1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 09/30/1999 | CA2324494A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/30/1999 | CA2324361A1 Anti-tumour agents |
| 09/30/1999 | CA2324347A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | CA2324345A1 Human vault rna |
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | CA2323760A1 Human casb12 polypeptide, a serine protease |
| 09/30/1999 | CA2323640A1 Human calcium-binding proteins |
| 09/30/1999 | CA2323605A1 Protein phosphatase-related molecules |
| 09/30/1999 | CA2323601A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | CA2323573A1 Medicament for preventing or treating papilloma virus-specific tumors |
| 09/30/1999 | CA2323526A1 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | CA2323501A1 Compounds related to pap-1 |
| 09/30/1999 | CA2322843A1 Hypoxia-inducible human genes, proteins, and uses thereof |
| 09/30/1999 | CA2322773A1 Antisense modulation of human mdm2 expression |
| 09/30/1999 | CA2319335A1 Anti-tumour agents |
| 09/30/1999 | CA2291066A1 Local delivery of long lasting therapeutic agents |
| 09/30/1999 | CA2267047A1 Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity |
| 09/29/1999 | EP0945436A1 Cytotrienins, process for preparing the same, and antitumor agent |
| 09/29/1999 | EP0944724A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE $g(b) AS MEDICINE |
| 09/29/1999 | EP0944722A2 Pituitary-tumor-transforming-genes, and related products |
| 09/29/1999 | EP0944721A1 Adipocyte-specific differentiation-related protein |
| 09/29/1999 | EP0944720A1 Adaptor protein frs2 and related products and methods |
| 09/29/1999 | EP0944651A2 Genes amplified in cancer cells |
| 09/29/1999 | EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944639A1 Synthetic glycoamines, methods for their use that affect cell |
| 09/29/1999 | EP0944634A1 Epothilone analogs |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944629A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/29/1999 | EP0944628A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/29/1999 | EP0944619A1 Novel integrin receptor antagonists |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944596A1 Seco precursors of cyclopropylindolines and their use as prodrugs |
| 09/29/1999 | EP0944594A1 Inhibitors of the enzymatic activity of psa |
| 09/29/1999 | EP0944592A1 Vitamin d3 derivatives |
| 09/29/1999 | EP0944587A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 09/29/1999 | EP0944582A1 Ketobenzamides as calpain inhibitors |
| 09/29/1999 | EP0944571A1 Asiatic acid derivatives having modified a-ring |
| 09/29/1999 | EP0944391A1 Use of equilenin as an antioxidant |
| 09/29/1999 | EP0944390A1 USE OF 17$g(b)-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
| 09/29/1999 | EP0944389A1 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 09/29/1999 | EP0944388A2 Inhibitors of farnesyl-protein transferase |
| 09/29/1999 | EP0944311A1 Heregulin antagonists and methods for their use |
| 09/29/1999 | EP0797447A4 Human cancer inhibitory pentapeptide heterocyclic and halophenyl amides |
| 09/29/1999 | EP0755399B1 Lobaplatinum trihydrate |
| 09/29/1999 | CN1230223A High-affinity interleukin-4 muteins |
| 09/29/1999 | CN1230222A PTX-sensitive G proteins, prodn. and use thereof |
| 09/29/1999 | CN1230220A Therapy for 'alpha'-galactosidase deficiency |
| 09/29/1999 | CN1230198A Therapeutic multispecific compounds comprised of anti-FC'alpha' receptor antibodies |
| 09/29/1999 | CN1230187A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230185A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230175A Cytostatic hydroxamic acid derivatives |
| 09/29/1999 | CN1230166A Illudin analogs useful as antitumor agents |
| 09/29/1999 | CN1230121A Means for treating prostate hypertrophy and prostate cancer |
| 09/29/1999 | CN1230120A Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 09/29/1999 | CN1230111A Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| 09/29/1999 | CN1229667A Pill for relief of choke |
| 09/29/1999 | CN1229663A Chinese medicinal prescription for treating liver cancer |
| 09/29/1999 | CN1045290C Method for preparation of chelans possesing ortho ligating functionality and complexes |
| 09/28/1999 | US5959145 12-(methoxy)dodecanoic acid. |
| 09/28/1999 | US5959125 Esterifying a baccatin iii derivative with an acid derivative; antitumor and anticarcinogenic agent |
| 09/28/1999 | US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections |
| 09/28/1999 | US5959113 Reacting a diketone derivative with an aldehyde derivative; administering to treat atherosclerosis, psoriasis, alopecia and tumors |
| 09/28/1999 | US5959084 Bispecific antibodies, methods of production and uses thereof |
| 09/28/1999 | US5958971 Chemical compounds |
| 09/28/1999 | US5958970 Tricyclic and tetracyclic pyrones |
| 09/28/1999 | US5958969 Osteoporosis |
| 09/28/1999 | US5958956 Aromatic carboxylic acid esters |
| 09/28/1999 | US5958939 Tricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseases |
| 09/28/1999 | US5958932 Antitumor agent |
| 09/28/1999 | US5958916 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 09/28/1999 | US5958892 2-methoxyestradiol-induced apoptosis in cancer cells |
| 09/28/1999 | US5958889 Anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 09/28/1999 | US5958872 Active survival domains of IGF-IR and methods of use |
| 09/28/1999 | US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression |
| 09/28/1999 | US5958771 Oligonucleotide from 8 to 30 nucleotides in length; for diagnosis and therapy; antitumor/antiinflammatory agents |
| 09/28/1999 | US5958770 Glycoalkaloids |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/28/1999 | US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases |
| 09/28/1999 | US5958725 Human DP1 homolog |
| 09/28/1999 | US5958711 Contacting a sample from a subject with an agent specific for said complex and determining interaction between said complex and said agent as a determination of said disorder |
| 09/28/1999 | US5958710 The receptor may be useful in isolating molecules for the treatment of disorders such as prostate cancer, benign prostatic hyperplasia, osteoporosis or cardiovascular disorders and in the testing of substances for estrogenic and |
| 09/28/1999 | US5958699 Hybridization probe comprising polynulceotide encoding polypeptide; for identifying and encoding nucleic acid and amino acid sequences and using them for diagnosis, prevention, and treatment of intestinal diseases including cancer |
| 09/28/1999 | US5958683 Screening method using the RZR receptor family |
| 09/28/1999 | US5958682 Virus-directed enzyme prodrug therapy for treating tumor cells consisting of a viral vector encoding bacterial nitroreductase capable of converting a prodrug into a cytotoxic drug operably linked to a promoter; and the prodrug |